Short vs Long Arm Cast for Distal Radius Fractures: the Verona Trial

NCT ID: NCT03468023

Last Updated: 2020-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

353 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-15

Study Completion Date

2020-03-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study prospectively compares the performance of an above-elbow cast (long arm cast) and a below-elbow cast (short arm cast) to maintain reduction in conservatively managed distal radius fractures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The choice of cast length in conservative management of distal radius fractures still represents a much debated controversy. Classic teaching was to immobilize the elbow to reduce risk of secondary displacement; however, short arm casts are felt to be equally effective with less complications and higher patient comfort. There is currently no conclusive evidence for or against immobilization of the elbow in patients treated with cast immobilization.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Radius Fracture Distal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Non-inferiority trial aimed at comparing the non inferiority of a short arm cast (below elbow cast) as opposed to a long arm cast (below elbow cast) in terms of fracture reduction maintenance ratio.

The sample size was selected as the highest required to test all non-inferiority thresholds and considering a drop-out percentage of 15%. Continuous values of all radiological parameters were used in order to keep results objective and reproducible.

At the end of recruitment observed drop-out percentage was 26%.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Short arm cast

Patient treated with below-elbow cast

Group Type EXPERIMENTAL

Short arm cast

Intervention Type PROCEDURE

Application of a below-elbow cast

Long arm cast

Patients treated with above-elbow cast

Group Type ACTIVE_COMPARATOR

Long arm cast

Intervention Type PROCEDURE

Application of an above-elbow cast

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Short arm cast

Application of a below-elbow cast

Intervention Type PROCEDURE

Long arm cast

Application of an above-elbow cast

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

below-elbow cast antebrachio-metacarpal cast above-elbow cast brachio-metacarpal cast

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of distal radius fracture
* Indication to conservative treatment
* Need for manipulation to reduce fracture

Exclusion Criteria

* Open fractures
* Existence of any skin lesion or wound that would impair cast treatment
* Neurovascular deficits
* Bilateral fractures
* Association with any other fracture of the homolateral arm
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Azienda Ospedaliera Universitaria Integrata Verona

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tommaso Maluta

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tommaso Maluta, MD

Role: STUDY_DIRECTOR

Azienda Ospedaliera Universitaria Integrata Verona

Giovanni Dib, MD

Role: PRINCIPAL_INVESTIGATOR

Azienda Ospedaliera Universitaria Integrata Verona

Matteo Cengarle, MD

Role: PRINCIPAL_INVESTIGATOR

Azienda Ospedaliera Universitaria Integrata Verona

Alice Bernasconi, DR

Role: PRINCIPAL_INVESTIGATOR

Azienda Ospedaliera Universitaria Integrata Verona

Franco Lavini, MD

Role: PRINCIPAL_INVESTIGATOR

Azienda Ospedaliera Universitaria Integrata Verona

Andrea Scalvi, MD

Role: STUDY_CHAIR

Azienda Ospedaliera Universitaria Integrata Verona

Bruno Magnan, MD

Role: STUDY_CHAIR

Azienda Ospedaliera Universitaria Integrata Verona

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ospedale Civile Maggiore Borgo Trento

Verona, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

References

Explore related publications, articles, or registry entries linked to this study.

Dib G, Maluta T, Cengarle M, Bernasconi A, Marconato G, Corain M, Magnan B. Short arm cast is as effective as long arm cast in maintaining distal radius fracture reduction: Results of the SLA-VER noninferiority trial. World J Orthop. 2022 Sep 18;13(9):802-811. doi: 10.5312/wjo.v13.i9.802. eCollection 2022 Sep 18.

Reference Type DERIVED
PMID: 36189333 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1166CESC

Identifier Type: REGISTRY

Identifier Source: secondary_id

1165CESC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.